Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,917 | -21,751 | -19,562 | -18,208 | -13,882 |
| Depreciation Amortization | 66 | 87 | 136 | 167 | 231 |
| Accounts receivable | 197 | -176 | -50 | 1 | 28 |
| Accounts payable and accrued liabilities | -2,378 | 941 | 1,357 | 1,090 | 55 |
| Other Working Capital | -2,729 | 1,174 | 714 | 1,037 | 8 |
| Other Operating Activity | 19,173 | 322 | -607 | 14 | 728 |
| Operating Cash Flow | $-23,588 | $-19,403 | $-18,012 | $-15,899 | $-12,832 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -179 | -1 | -13 | -221 |
| Investing Cash Flow | $-18 | $-179 | $-1 | $-13 | $-221 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 72,804 | 73,921 | 17,884 | N/A | 25,750 |
| Other Financing Activity | -2,319 | -5,892 | -1,869 | 0 | -3,228 |
| Financing Cash Flow | $70,485 | $68,029 | $16,015 | $N/A | $22,522 |
| Exchange Rate Effect | 49 | -8 | 412 | 204 | 499 |
| Beginning Cash Position | 50,929 | 2,490 | 4,076 | 19,784 | 9,816 |
| End Cash Position | 97,857 | 50,929 | 2,490 | 4,076 | 19,784 |
| Net Cash Flow | $46,928 | $48,439 | $-1,586 | $-15,708 | $9,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,588 | -19,403 | -18,012 | -15,899 | -12,832 |
| Capital Expenditure | -18 | -179 | -1 | -13 | -221 |
| Free Cash Flow | -23,606 | -19,582 | -18,013 | -15,912 | -13,053 |